Cognitive remission: A novel objective for the treatment of major depression?
Version 3 2024-06-17, 17:17
Version 2 2024-06-03, 19:24
Version 1 2016-02-11, 21:11
journal contribution
posted on 2024-06-17, 17:17 authored by B Bortolato, KW Miskowiak, CA Köhler, M Maes, BS Fernandes, Michael BerkMichael Berk, AF CarvalhoCognitive remission: A novel objective for the treatment of major depression?
History
Journal
BMC MedicineVolume
14Article number
ARTN 9Location
EnglandOpen access
- Yes
ISSN
1741-7015eISSN
1741-7015Language
EnglishPublication classification
C Journal article, C1 Refereed article in a scholarly journalCopyright notice
2016, The AuthorsIssue
1Publisher
BMCUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal MedicineAntidepressantsCognitionCognitive enhancersErythropoietinLisdexamfetamine dimesylateMajor depressionNovel targetsVortioxetinePsychiatryTREATMENT-RESISTANT DEPRESSIONACETYL-L-CARNITINEALPHA-LIPOIC ACIDDIRECT-CURRENT STIMULATIONDOUBLE-BLINDCONTROLLED-TRIALEXECUTIVE DYSFUNCTIONTREATMENT RESPONSEUNIPOLAR DEPRESSIONBIPOLAR DISORDERFaculty of HealthSchool of MedicineInnovation in Mental and Physical Health and Clinical Treatment110319 Psychiatry (incl Psychotherapy)920410 Mental Health3202 Clinical sciences420313 Mental health services200409 Mental health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC